EX-FILING FEES 5 tm2312861d2_exfiling-fees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Carisma Therapeutics Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

                         
  Security
Type

Security

Class

Title

Fee

Calculation
or Carry
Forward
Rule

Amount
Registered
Proposed
Maximum
Offering
Price Per
Unit
Maximum
Aggregate
Offering
Price
Fee
Rate
Amount of
Registration
Fee

Carry
Forward

Form
Type

Carry
Forward
File

Number

Carry
Forward

Initial
Effective
Date

Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
Newly Registered Securities

Fees to Be

Paid

Equity Common Stock, $0.001 par value per share Other 3,730,608 (1)  $2.80(2)  $ $10,445,703(2) 

$110.20 per

$1,000,000

$1,151.12        

Fees

Previously

Paid

       
Carry Forward Securities

Carry

Forward

Securities

  Total Offering Amounts   $10,445,703(2)  $1,151.12          
  Total Fees Previously Paid              
  Total Fee Offsets              
  Net Fee Due       $1,151.12        

(1) The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained in the registration statement to which this exhibit is attached. The registration statement registers the resale of an aggregate of 3,730,608 shares of the registrant’s common stock. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events.

(2) This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The proposed maximum offering price per share and maximum aggregate offering price are based upon the average of the high and low sales prices of the registrant’s common stock on April 10, 2023, as reported on The Nasdaq Global Market.